We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$337M
AUM Growth
-$8.73M
Cap. Flow
-$4.66M
Cap. Flow %
-1.38%
Top 10 Hldgs %
36.68%
Holding
216
New
7
Increased
44
Reduced
112
Closed
8

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$732K
2
ELV icon
Elevance Health
ELV
+$644K
3
ADBE icon
Adobe
ADBE
+$573K
4
VBR icon
Vanguard Morningstar Small-Cap Value ETF
VBR
+$510K
5
NKE icon
Nike
NKE
+$337K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$906K
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$623K
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$587K
4
EL icon
Estee Lauder
EL
+$507K
5
GPN icon
Global Payments
GPN
+$433K

Sector Composition

Rank Sector Weight
1 Technology 18.56%
2 Healthcare 15.23%
3 Financials 13.1%
4 Industrials 8.56%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SF
151
Stifel
SF
$12.6B
$347K 0.1%
4,913
-300
-6% -$21.4K
QQQ icon
152
Invesco QQQ Trust
QQQ
$453B
$346K 0.1%
677
-9
-1% -$4.55K
NTRS icon
153
Northern Trust
NTRS
$22.4B
$346K 0.1%
3,371
-25
-0.7% -$2.56K
QCOM icon
154
Qualcomm
QCOM
$155B
$344K 0.1%
2,238
– –
AZN icon
155
AstraZeneca
AZN
$263B
$337K 0.1%
2,575
+252
+11% +$35.3K
NOC icon
156
Northrop Grumman
NOC
$77.1B
$333K 0.1%
710
-60
-8% -$30.2K
PANW icon
157
Palo Alto Networks
PANW
$270B
$333K 0.1%
1,828
– –
EMR icon
158
Emerson Electric
EMR
$83.9B
$331K 0.1%
2,673
– –
UL icon
159
Unilever
UL
$137B
$331K 0.1%
5,192
-89
-2% -$6.01K
BP icon
160
BP
BP
$116B
$331K 0.1%
11,194
– –
NKE icon
161
Nike
NKE
$61.9B
$324K 0.1%
+4,286
New +$337K
GE icon
162
GE Aerospace
GE
$374B
$323K 0.1%
1,939
– –
CBOE icon
163
Cboe Global Markets
CBOE
$32.5B
$320K 0.1%
1,638
– –
EVLV icon
164
Evolv Technologies
EVLV
$995M
$314K 0.09%
79,500
+30,500
+62% +$107K
CHD icon
165
Church & Dwight Co
CHD
$23.4B
$312K 0.09%
2,980
– –
NEM icon
166
Newmont
NEM
$98.7B
$310K 0.09%
8,318
+635
+8% +$28.9K
USLM icon
167
United States Lime & Minerals
USLM
$3.16B
$305K 0.09%
2,300
-455
-17% -$57.7K
WAB icon
168
Wabtec
WAB
$49.1B
$299K 0.09%
1,577
-85
-5% -$16.5K
AMN icon
169
AMN Healthcare
AMN
$1.3B
$296K 0.09%
12,375
-1,585
-11% -$50.4K
COP icon
170
ConocoPhillips
COP
$147B
$296K 0.09%
2,985
+507
+20% +$53.8K
LRCX icon
171
Lam Research
LRCX
$367B
$289K 0.09%
4,005
+225
+6% +$17.1K
VMC icon
172
Vulcan Materials
VMC
$34.8B
$286K 0.08%
1,111
– –
USCI icon
173
US Commodity Index
USCI
$369M
$285K 0.08%
4,315
– –
SAMG icon
174
Silvercrest Asset Management
SAMG
$79M
$271K 0.08%
14,733
+300
+2% +$5.32K
BAX icon
175
Baxter International
BAX
$13.5B
$271K 0.08%
9,284
-5,360
-37% -$180K
5 6
7
8 9

Similar funds

VBFP
Valtinson Bruner Financial Planning New Brighton, Minnesota $364M AUM 9.63% 1-Year Est. Return
EW
Evexia Wealth Stevens Point, Wisconsin $364M AUM 29.61% 1-Year Est. Return
RBFC
Roman Butler Fullerton & Co St Louis, Missouri $364M AUM 27.64% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $365M AUM
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return
SWA
Strata Wealth Advisors Dallas, Texas $365M AUM 16.8% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Roberts, Glore & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Roberts, Glore & Co held 216 positions worth $337M, down 2.5% from $346M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Roberts, Glore & Co's Q4 2024 filing shows 7 new, 44 increased, 112 reduced and 8 closed positions. Its largest new stake was ASML: 1,020 shares worth $707K. The largest sale was CVS Health, an estimated $906K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q4 2024 buy was ASML: 1,020 shares worth $707K.
  • Roberts, Glore & Co added most to Elevance Health in Q4 2024, an estimated $644K increase.
  • Roberts, Glore & Co's biggest Q4 2024 reduction was CVS Health, cutting an estimated $906K.
  • Roberts, Glore & Co fully exited Estee Lauder in Q4 2024, selling an estimated $507K.
  • Roberts, Glore & Co's ten largest holdings make up 37% of its $337M portfolio in Q4 2024.
  • Roberts, Glore & Co opened 7 new positions and closed 8 in Q4 2024.
  • Roberts, Glore & Co's portfolio value fell 2.5% quarter-over-quarter to $337M.

Based on Roberts, Glore & Co's 13F filing for Q4 2024, filed 7 Feb 2025.